Menu

Markets

Research

News

Learn
Paper trading
AI Chat
WatchlistsPortfoliosAlerts
Sign in

9 Meters Biopharma, Inc. NMTR

Set alert

Price alert · NMTR

All alert types
0.07 +0.07 —

Day range unavailable

52-week range unavailable

Open
—
Prev close
0.00
Mkt cap
9.76M
Vol
0
Avg vol
0
EPS
0.00
P/E
0.00
Div yield
0.00%
More statistics
Low
—
High
—
Forward P/E
-0.27
Beta
1.48
Short ratio
7.78
Inst. own
16.43%
Dividend
0.00
Ex-div date
Earnings
Aug 21, 2023
50-d avg
0.7188
200-d avg
1.73
1y target
10.38

3M chart

Chart tools
Interval
1m5m15m30m

Events in this range
  • May 15, 2023Earnings: —; estimate -0.79; surprise —%
  • May 18, 2023Rating: Citigroup · Neutral → Neutral
  • Jun 1, 2023Rating: Citigroup · Neutral → Neutral
Signals (6)
NameDateAgo
MACD: Sell SignalJul 18, 20233 years ago
RSI: OversoldJul 18, 20233 years ago
SMA: BearishJun 9, 20233 years ago
SMA: BullishJun 8, 20233 years ago
MACD: Buy SignalMay 12, 20233 years ago
RSI: OversoldMay 11, 20233 years ago

Financial health

Altman Z-Score

-49.99 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

2 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

Valuation

P/E -0.4×
FY 2013: -5.7×FY 2014: -1.8×FY 2015: -2.2×FY 2016: -1.6×FY 2017: -9.2×FY 2018: -2.4×FY 2019: -0.6×FY 2020: -1.4×FY 2021: -6.5×FY 2022: -0.4×
FY 2013 5y median -1.4× FY 2022
P/S 0.0×
FY 2013: 5.6×FY 2014: 1.7×FY 2015: 2.4×FY 2016: 2.4×FY 2017: 38.5×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×
FY 2013 5y median 0.0× FY 2022
P/B 6.8×
FY 2013: -36.3×FY 2014: -3.9×FY 2015: -3.4×FY 2016: 3.9×FY 2017: -36.8×FY 2018: -15.6×FY 2019: -1.9×FY 2020: 2.8×FY 2021: 5.7×FY 2022: 6.8×
FY 2013 5y median 2.8× FY 2022
P/FCF -0.4×
FY 2013: -5.0×FY 2014: -2.6×FY 2015: -11.2×FY 2016: -1.1×FY 2017: -18.1×FY 2018: -3.8×FY 2019: -1.0×FY 2020: -4.0×FY 2021: -7.4×FY 2022: -0.4×
FY 2013 5y median -3.8× FY 2022
EV/EBITDA -0.6×
FY 2013: -6.0×FY 2014: -3.1×FY 2015: -3.2×FY 2016: -1.4×FY 2017: -13.1×FY 2018: -3.1×FY 2019: -0.0×FY 2020: -0.0×FY 2021: -4.6×FY 2022: -0.6×
FY 2013 5y median -0.6× FY 2022
EV/Sales 0.0×
FY 2013: 5.9×FY 2014: 2.2×FY 2015: 2.8×FY 2016: 2.0×FY 2017: 39.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×
FY 2013 5y median 0.0× FY 2022
FCF Yield -228.2%
FY 2013: -19.9%FY 2014: -38.1%FY 2015: -8.9%FY 2016: -87.2%FY 2017: -5.5%FY 2018: -26.5%FY 2019: -96.9%FY 2020: -24.9%FY 2021: -13.4%FY 2022: -228.2%
FY 2013 5y median -26.5% FY 2022

Profitability

Gross Margin 0.0%
FY 2013: 17.6%FY 2014: 2.1%FY 2015: 5.2%FY 2016: 18.1%FY 2017: -3.4%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%
FY 2013 5y median 0.0% FY 2022
Operating Margin 0.0%
FY 2013: -115.3%FY 2014: -60.9%FY 2015: -83.3%FY 2016: -164.3%FY 2017: -472.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%
FY 2013 5y median 0.0% FY 2022
Net Margin 0.0%
FY 2013: -99.7%FY 2014: -97.5%FY 2015: -105.7%FY 2016: -152.8%FY 2017: -420.9%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%
FY 2013 5y median 0.0% FY 2022
ROE -1896.1%
FY 2013: 640.9%FY 2014: 221.7%FY 2015: 153.5%FY 2016: -249.7%FY 2017: 401.7%FY 2018: 660.3%FY 2019: 300.3%FY 2020: -203.9%FY 2021: -88.5%FY 2022: -1896.1%
FY 2013 5y median -88.5% FY 2022
ROIC -189.9%
FY 2013: -1569.6%FY 2014: -7051.0%FY 2015: 461.8%FY 2016: -264.4%FY 2017: 1447.6%FY 2018: -1185.2%FY 2019: 400.0%FY 2020: -188.1%FY 2021: -88.0%FY 2022: -189.9%
FY 2013 5y median -188.1% FY 2022
ROA -137.3%
FY 2013: -177.9%FY 2014: -172.5%FY 2015: -168.1%FY 2016: -96.1%FY 2017: -1170.6%FY 2018: -374.4%FY 2019: -545.1%FY 2020: -167.4%FY 2021: -73.4%FY 2022: -137.3%
FY 2013 5y median -167.4% FY 2022

Growth (YoY)

Revenue 0.0%
FY 2013: 0.0%FY 2014: 229.4%FY 2015: -27.1%FY 2016: -50.8%FY 2017: -53.7%FY 2018: -100.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%
FY 2013 FY 2022
Operating Income -14.3%
FY 2013: 0.0%FY 2014: -74.0%FY 2015: 0.3%FY 2016: 3.0%FY 2017: -33.1%FY 2018: -105.0%FY 2019: -40.2%FY 2020: -138.3%FY 2021: 39.6%FY 2022: -14.3%
FY 2013 FY 2022
EPS (diluted) -15.8%
FY 2013: 0.0%FY 2014: -221.9%FY 2015: 20.9%FY 2016: 31.6%FY 2017: 94.1%FY 2018: -47.0%FY 2019: 17.3%FY 2020: 28.4%FY 2021: 73.9%FY 2022: -15.8%
FY 2013 FY 2022
Free Cash Flow -16.5%
FY 2013: 0.0%FY 2014: -92.5%FY 2015: 76.8%FY 2016: -387.1%FY 2017: 52.5%FY 2018: -279.4%FY 2019: -18.4%FY 2020: -25.7%FY 2021: -41.5%FY 2022: -16.5%
FY 2013 FY 2022

Financial Health

Current Ratio 1.1×
FY 2013: 0.8×FY 2014: 0.6×FY 2015: 0.1×FY 2016: 1.0×FY 2017: 0.3×FY 2018: 0.6×FY 2019: 0.4×FY 2020: 5.7×FY 2021: 5.9×FY 2022: 1.1×
FY 2013 5y median 1.1× FY 2022
Quick Ratio 1.1×
FY 2013: 0.5×FY 2014: 0.3×FY 2015: 0.1×FY 2016: 0.7×FY 2017: 0.2×FY 2018: 0.6×FY 2019: 0.4×FY 2020: 5.7×FY 2021: 5.9×FY 2022: 1.1×
FY 2013 5y median 1.1× FY 2022
Debt / Equity 8.2×
FY 2013: -1.5×FY 2014: -1.0×FY 2015: -0.7×FY 2016: 0.0×FY 2017: -0.7×FY 2018: -1.4×FY 2019: -0.3×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 8.2×
FY 2013 5y median 0.0× FY 2022
Net Debt / EBITDA -0.2×
FY 2013: -0.2×FY 2014: -0.6×FY 2015: -0.6×FY 2016: 0.2×FY 2017: -0.2×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 1.1×FY 2022: -0.2×
FY 2013 5y median 0.0× FY 2022
Interest Coverage -15.8×
FY 2013: -60.2×FY 2014: -4.2×FY 2015: -5.0×FY 2016: -8.1×FY 2017: -95.6×FY 2018: -3.0×FY 2019: -14.0×FY 2020: -15.0×FY 2021: -779×FY 2022: -15.8×
FY 2013 5y median -15.0× FY 2022

Dividends

Dividend Yield 0.0%
FY 2013: 0.0%FY 2014: 0.0%FY 2015: 0.0%FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%
FY 2013 5y median 0.0% FY 2022
Payout Ratio 0.0%
FY 2013: 0.0%FY 2014: 0.0%FY 2015: 0.0%FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%
FY 2013 5y median 0.0% FY 2022

Annual · latest fiscal year ends 2022-12-31